Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
6.38
-0.01 (-0.16%)
At close: Oct 10, 2025, 4:00 PM EDT
6.30
-0.08 (-1.25%)
After-hours: Oct 10, 2025, 7:06 PM EDT
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $260.65 million as of October 10, 2025. Its market cap has decreased by -18.10% in one year.
Market Cap
260.65M
Enterprise Value
236.73M
1-Year Change
-18.10%
Ranking
Category
Stock Price
$6.38
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $260.65M, a decrease of -48.50%. That is a compound annual growth rate of -13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 260.65M | -18.56% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 762.95B |
| Johnson & Johnson | 460.38B |
| AbbVie | 412.35B |
| UnitedHealth Group | 323.51B |
| AstraZeneca | 266.87B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 231.67B |